Acidosis and Hyperkalemia Caused By Losartan and Enalapril in Pediatric Kidney Transplant Recipients.

CONCLUSIONS: Losartan and enalapril may be beneficial in pediatric kidney transplant recipients by decreasing blood pressure and proteinuria, with maintenance of stable graft function, but may be associated with serious adverse events including hyperkalemia and life-threatening acidosis. PMID: 24447308 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24447308?dopt=Abstract

Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - January 20, 2014 Category: Transplant Surgery Authors: Sakallı H, Baskın E, Bayrakcı US, Moray G, Haberal M Tags: Exp Clin Transplant Source Type: research